APO Research
Talk to an analyst

APO RESEARCH · REPORT

Taurine Eye Drop

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Taurine Eye Drop Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025190 pages

Choose your research edition.

Industry ResearchTaurine Eye Drop Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Taurine Eye Drop Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Taurine Eye Drop Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Taurine Eye Drop Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Taurine Eye Drop Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Taurine Eye Drop market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Taurine Eye Drop is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Taurine Eye Drop is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Taurine Eye Drop is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Taurine Eye Drop is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Taurine Eye Drop include Changchun Changqing Pharmaceutical Group Co., Ltd., Changchun Dirui Pharmaceutical Co., Ltd., Wuhan Wujing Pharmaceutical Co., Ltd., Shijiazhuang Grey Pharmaceutical Co., Ltd., Shenyang Xingqi Eye Medicine Co., Ltd., Shanghai Xiaofang Pharmaceutical Co., Ltd., Shandong Chenxin Fodu Pharmaceutical Co., Ltd., Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. and Ningxia Kangya Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Taurine Eye Drop market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Taurine Eye Drop and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Taurine Eye Drop sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Taurine Eye Drop market size, projected growth trends, production technologies, key applications, and end-use industries.

Taurine Eye Drop Segment by Company

Changchun Changqing Pharmaceutical Group Co., Ltd.

Changchun Dirui Pharmaceutical Co., Ltd.

Wuhan Wujing Pharmaceutical Co., Ltd.

Shijiazhuang Grey Pharmaceutical Co., Ltd.

Shenyang Xingqi Eye Medicine Co., Ltd.

Shanghai Xiaofang Pharmaceutical Co., Ltd.

Shandong Chenxin Fodu Pharmaceutical Co., Ltd.

Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.

Ningxia Kangya Pharmaceutical Co., Ltd.

Mentholatum

Liaoning Yifan Pharmaceutical Co., Ltd.

Liaoning Qianliming Pharmaceutical (Group) Co., Ltd.

Roxy Pharmaceutical Shijiazhuang Co., Ltd.

Jiangxi Zhenshiming Pharmaceutical Co., Ltd.

Jiangsu Yuanheng Pharmaceutical Co., Ltd.

Jiangsu Jibei Pharmaceutical Co., Ltd.

Hubei Zhongjia Pharmaceutical Co., Ltd.

Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd.

Heilongjiang Tianlong Pharmaceutical Co., Ltd.

Hangzhou Guoguang Pharmaceutical Co., Ltd.

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Guangdong Matsushita Pharmaceutical Co., Ltd.

Guangdong Nanguo Pharmaceutical Co., Ltd.

Guangdong Hengjian Pharmaceutical Co., Ltd.

Taurine Eye Drop Segment by Type

5ml

10ml

Others

Taurine Eye Drop Segment by Application

Online Sales

Offline Sales

Taurine Eye Drop Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taurine Eye Drop market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Taurine Eye Drop and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taurine Eye Drop.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Taurine Eye Drop market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Taurine Eye Drop manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Taurine Eye Drop in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Taurine Eye Drop in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Taurine Eye Drop Industry Trends Table 2. Taurine Eye Drop Industry Drivers Table 3. Taurine Eye Drop Industry Opportunities and Challenges Table 4. Taurine Eye Drop Industry Restraints Table 5. Global Taurine Eye Drop Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Taurine Eye Drop Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Taurine Eye Drop Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Taurine Eye Drop Sales Market Share by Manufacturers Table 9. Global Taurine Eye Drop Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Taurine Eye Drop Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Taurine Eye Drop Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Taurine Eye Drop Manufacturers, Product Type & Application Table 13. Global Taurine Eye Drop Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Taurine Eye Drop by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5ml Table 17. Major Manufacturers of 10ml Table 18. Major Manufacturers of Others Table 19. Global Taurine Eye Drop Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Taurine Eye Drop Sales by Type (2021-2026) & (K Units) Table 21. Global Taurine Eye Drop Sales by Type (2027-2032) & (K Units) Table 22. Global Taurine Eye Drop Sales Market Share by Type (2021-2026) Table 23. Global Taurine Eye Drop Sales Market Share by Type (2027-2032) Table 24. Global Taurine Eye Drop Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Taurine Eye Drop Revenue by Type (2021-2026) & (K Units) Table 26. Global Taurine Eye Drop Revenue by Type (2027-2032) & (K Units) Table 27. Global Taurine Eye Drop Revenue Market Share by Type (2021-2026) Table 28. Global Taurine Eye Drop Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Online Sales Table 30. Major Manufacturers of Offline Sales Table 31. Global Taurine Eye Drop Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Taurine Eye Drop Sales by Application (2021-2026) & (K Units) Table 33. Global Taurine Eye Drop Sales by Application (2027-2032) & (K Units) Table 34. Global Taurine Eye Drop Sales Market Share by Application (2021-2026) Table 35. Global Taurine Eye Drop Sales Market Share by Application (2027-2032) Table 36. Global Taurine Eye Drop Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Taurine Eye Drop Revenue by Application (2021-2026) & (K Units) Table 38. Global Taurine Eye Drop Revenue by Application (2027-2032) & (K Units) Table 39. Global Taurine Eye Drop Revenue Market Share by Application (2021-2026) Table 40. Global Taurine Eye Drop Revenue Market Share by Application (2027-2032) Table 41. Global Taurine Eye Drop Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Taurine Eye Drop Sales by Region (2021-2026) & (K Units) Table 43. Global Taurine Eye Drop Sales Market Share by Region (2021-2026) Table 44. Global Taurine Eye Drop Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Taurine Eye Drop Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Taurine Eye Drop Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Taurine Eye Drop Sales by Country (2021-2026) & (K Units) Table 48. North America Taurine Eye Drop Sales by Country (2027-2032) & (K Units) Table 49. Europe Taurine Eye Drop Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Taurine Eye Drop Sales by Country (2021-2026) & (K Units) Table 51. Europe Taurine Eye Drop Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Taurine Eye Drop Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Taurine Eye Drop Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Taurine Eye Drop Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Taurine Eye Drop Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Taurine Eye Drop Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Taurine Eye Drop Sales by Country (2027-2032) & (K Units) Table 58. Global Taurine Eye Drop Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Taurine Eye Drop Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Taurine Eye Drop Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Taurine Eye Drop Revenue Market Share by Region (2021-2026) Table 62. Global Taurine Eye Drop Revenue Market Share by Region (2027-2032) Table 63. Changchun Changqing Pharmaceutical Group Co., Ltd. Company Information Table 64. Changchun Changqing Pharmaceutical Group Co., Ltd. Business Overview Table 65. Changchun Changqing Pharmaceutical Group Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Changchun Changqing Pharmaceutical Group Co., Ltd. Taurine Eye Drop Product Portfolio Table 67. Changchun Changqing Pharmaceutical Group Co., Ltd. Recent Development Table 68. Changchun Dirui Pharmaceutical Co., Ltd. Company Information Table 69. Changchun Dirui Pharmaceutical Co., Ltd. Business Overview Table 70. Changchun Dirui Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Changchun Dirui Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 72. Changchun Dirui Pharmaceutical Co., Ltd. Recent Development Table 73. Wuhan Wujing Pharmaceutical Co., Ltd. Company Information Table 74. Wuhan Wujing Pharmaceutical Co., Ltd. Business Overview Table 75. Wuhan Wujing Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Wuhan Wujing Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 77. Wuhan Wujing Pharmaceutical Co., Ltd. Recent Development Table 78. Shijiazhuang Grey Pharmaceutical Co., Ltd. Company Information Table 79. Shijiazhuang Grey Pharmaceutical Co., Ltd. Business Overview Table 80. Shijiazhuang Grey Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shijiazhuang Grey Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 82. Shijiazhuang Grey Pharmaceutical Co., Ltd. Recent Development Table 83. Shenyang Xingqi Eye Medicine Co., Ltd. Company Information Table 84. Shenyang Xingqi Eye Medicine Co., Ltd. Business Overview Table 85. Shenyang Xingqi Eye Medicine Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shenyang Xingqi Eye Medicine Co., Ltd. Taurine Eye Drop Product Portfolio Table 87. Shenyang Xingqi Eye Medicine Co., Ltd. Recent Development Table 88. Shanghai Xiaofang Pharmaceutical Co., Ltd. Company Information Table 89. Shanghai Xiaofang Pharmaceutical Co., Ltd. Business Overview Table 90. Shanghai Xiaofang Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shanghai Xiaofang Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 92. Shanghai Xiaofang Pharmaceutical Co., Ltd. Recent Development Table 93. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information Table 94. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview Table 95. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 97. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Development Table 98. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information Table 99. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview Table 100. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 102. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Development Table 103. Ningxia Kangya Pharmaceutical Co., Ltd. Company Information Table 104. Ningxia Kangya Pharmaceutical Co., Ltd. Business Overview Table 105. Ningxia Kangya Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Ningxia Kangya Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 107. Ningxia Kangya Pharmaceutical Co., Ltd. Recent Development Table 108. Mentholatum Company Information Table 109. Mentholatum Business Overview Table 110. Mentholatum Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Mentholatum Taurine Eye Drop Product Portfolio Table 112. Mentholatum Recent Development Table 113. Liaoning Yifan Pharmaceutical Co., Ltd. Company Information Table 114. Liaoning Yifan Pharmaceutical Co., Ltd. Business Overview Table 115. Liaoning Yifan Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Liaoning Yifan Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 117. Liaoning Yifan Pharmaceutical Co., Ltd. Recent Development Table 118. Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Company Information Table 119. Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Business Overview Table 120. Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Taurine Eye Drop Product Portfolio Table 122. Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Recent Development Table 123. Roxy Pharmaceutical Shijiazhuang Co., Ltd. Company Information Table 124. Roxy Pharmaceutical Shijiazhuang Co., Ltd. Business Overview Table 125. Roxy Pharmaceutical Shijiazhuang Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Roxy Pharmaceutical Shijiazhuang Co., Ltd. Taurine Eye Drop Product Portfolio Table 127. Roxy Pharmaceutical Shijiazhuang Co., Ltd. Recent Development Table 128. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Company Information Table 129. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Business Overview Table 130. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 132. Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Recent Development Table 133. Jiangsu Yuanheng Pharmaceutical Co., Ltd. Company Information Table 134. Jiangsu Yuanheng Pharmaceutical Co., Ltd. Business Overview Table 135. Jiangsu Yuanheng Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Jiangsu Yuanheng Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 137. Jiangsu Yuanheng Pharmaceutical Co., Ltd. Recent Development Table 138. Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information Table 139. Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview Table 140. Jiangsu Jibei Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Jiangsu Jibei Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 142. Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Development Table 143. Hubei Zhongjia Pharmaceutical Co., Ltd. Company Information Table 144. Hubei Zhongjia Pharmaceutical Co., Ltd. Business Overview Table 145. Hubei Zhongjia Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Hubei Zhongjia Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 147. Hubei Zhongjia Pharmaceutical Co., Ltd. Recent Development Table 148. Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Company Information Table 149. Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Business Overview Table 150. Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 152. Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Recent Development Table 153. Heilongjiang Tianlong Pharmaceutical Co., Ltd. Company Information Table 154. Heilongjiang Tianlong Pharmaceutical Co., Ltd. Business Overview Table 155. Heilongjiang Tianlong Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Heilongjiang Tianlong Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 157. Heilongjiang Tianlong Pharmaceutical Co., Ltd. Recent Development Table 158. Hangzhou Guoguang Pharmaceutical Co., Ltd. Company Information Table 159. Hangzhou Guoguang Pharmaceutical Co., Ltd. Business Overview Table 160. Hangzhou Guoguang Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Hangzhou Guoguang Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 162. Hangzhou Guoguang Pharmaceutical Co., Ltd. Recent Development Table 163. Guangdong Zhongsheng Pharmaceutical Co., Ltd. Company Information Table 164. Guangdong Zhongsheng Pharmaceutical Co., Ltd. Business Overview Table 165. Guangdong Zhongsheng Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Guangdong Zhongsheng Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 167. Guangdong Zhongsheng Pharmaceutical Co., Ltd. Recent Development Table 168. Guangdong Matsushita Pharmaceutical Co., Ltd. Company Information Table 169. Guangdong Matsushita Pharmaceutical Co., Ltd. Business Overview Table 170. Guangdong Matsushita Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Guangdong Matsushita Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 172. Guangdong Matsushita Pharmaceutical Co., Ltd. Recent Development Table 173. Guangdong Nanguo Pharmaceutical Co., Ltd. Company Information Table 174. Guangdong Nanguo Pharmaceutical Co., Ltd. Business Overview Table 175. Guangdong Nanguo Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Guangdong Nanguo Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 177. Guangdong Nanguo Pharmaceutical Co., Ltd. Recent Development Table 178. Guangdong Hengjian Pharmaceutical Co., Ltd. Company Information Table 179. Guangdong Hengjian Pharmaceutical Co., Ltd. Business Overview Table 180. Guangdong Hengjian Pharmaceutical Co., Ltd. Taurine Eye Drop Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 181. Guangdong Hengjian Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio Table 182. Guangdong Hengjian Pharmaceutical Co., Ltd. Recent Development Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Taurine Eye Drop Distributors List Table 186. Taurine Eye Drop Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Taurine Eye Drop Product Image Figure 2. Global Taurine Eye Drop Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Taurine Eye Drop Market Size (2021-2032) & (US$ Million) Figure 4. Global Taurine Eye Drop Sales (2021-2032) & (K Units) Figure 5. Global Taurine Eye Drop Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Taurine Eye Drop Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5ml Image Figure 9. 10ml Image Figure 10. Others Image Figure 11. Global Taurine Eye Drop Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Taurine Eye Drop Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Taurine Eye Drop Sales Market Share by Type (2021-2032) Figure 14. Global Taurine Eye Drop Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Taurine Eye Drop Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Taurine Eye Drop Revenue Market Share by Type (2021-2032) Figure 17. Online Sales Image Figure 18. Offline Sales Image Figure 19. Global Taurine Eye Drop Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Taurine Eye Drop Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Taurine Eye Drop Sales Market Share by Application (2021-2032) Figure 22. Global Taurine Eye Drop Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Taurine Eye Drop Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Taurine Eye Drop Revenue Market Share by Application (2021-2032) Figure 25. North America Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Taurine Eye Drop Sales Market Share by Country (2021-2032) Figure 27. U.S. Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Taurine Eye Drop Sales Market Share by Country (2021-2032) Figure 32. Germany Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Taurine Eye Drop Sales Market Share by Country (2021-2032) Figure 39. China Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Taurine Eye Drop Sales Market Share by Country (2021-2032) Figure 47. Brazil Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Taurine Eye Drop Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Taurine Eye Drop Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Taurine Eye Drop Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Taurine Eye Drop Revenue (2021-2032) & (US$ Million) Figure 58. North America Taurine Eye Drop Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Taurine Eye Drop Revenue (2021-2032) & (US$ Million) Figure 60. Europe Taurine Eye Drop Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Taurine Eye Drop Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Taurine Eye Drop Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Taurine Eye Drop Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Taurine Eye Drop Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Taurine Eye Drop Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Taurine Eye Drop Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 5ml
  • 10ml
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Changchun Changqing Pharmaceutical Group Co., Ltd.
  • Changchun Dirui Pharmaceutical Co., Ltd.
  • Wuhan Wujing Pharmaceutical Co., Ltd.
  • Shijiazhuang Grey Pharmaceutical Co., Ltd.
  • Shenyang Xingqi Eye Medicine Co., Ltd.
  • Shanghai Xiaofang Pharmaceutical Co., Ltd.
  • Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  • Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  • Ningxia Kangya Pharmaceutical Co., Ltd.
  • Mentholatum
  • Liaoning Yifan Pharmaceutical Co., Ltd.
  • Liaoning Qianliming Pharmaceutical (Group) Co., Ltd.
  • Roxy Pharmaceutical Shijiazhuang Co., Ltd.
  • Jiangxi Zhenshiming Pharmaceutical Co., Ltd.
  • Jiangsu Yuanheng Pharmaceutical Co., Ltd.
  • Jiangsu Jibei Pharmaceutical Co., Ltd.
  • Hubei Zhongjia Pharmaceutical Co., Ltd.
  • Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd.
  • Heilongjiang Tianlong Pharmaceutical Co., Ltd.
  • Hangzhou Guoguang Pharmaceutical Co., Ltd.
  • Guangdong Zhongsheng Pharmaceutical Co., Ltd.
  • Guangdong Matsushita Pharmaceutical Co., Ltd.
  • Guangdong Nanguo Pharmaceutical Co., Ltd.
  • Guangdong Hengjian Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Taurine Eye Drop Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Taurine Eye Drop Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Taurine Eye Drop Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Taurine Eye Drop Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Taurine Eye Drop Market Dynamics
  1. 2.1 Taurine Eye Drop Industry Trends
  2. 2.2 Taurine Eye Drop Industry Drivers
  3. 2.3 Taurine Eye Drop Industry Opportunities and Challenges
  4. 2.4 Taurine Eye Drop Industry Restraints
3 Taurine Eye Drop Market by Manufacturers
  1. 3.1 Global Taurine Eye Drop Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Taurine Eye Drop Sales by Manufacturers (2021-2026)
  3. 3.3 Global Taurine Eye Drop Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Taurine Eye Drop Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Taurine Eye Drop Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Taurine Eye Drop Manufacturers, Product Type & Application
  7. 3.7 Global Taurine Eye Drop Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Taurine Eye Drop Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Taurine Eye Drop Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Taurine Eye Drop Tier 1, Tier 2, and Tier 3
4 Taurine Eye Drop Market by Type
  1. 4.1 Taurine Eye Drop Type Introduction
  2. 4.1.1 5ml
  3. 4.1.2 10ml
  4. 4.1.3 Others
  5. 4.2 Global Taurine Eye Drop Sales by Type
  6. 4.2.1 Global Taurine Eye Drop Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Taurine Eye Drop Sales by Type (2021-2032)
  8. 4.2.3 Global Taurine Eye Drop Sales Market Share by Type (2021-2032)
  9. 4.3 Global Taurine Eye Drop Revenue by Type
  10. 4.3.1 Global Taurine Eye Drop Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Taurine Eye Drop Revenue by Type (2021-2032)
  12. 4.3.3 Global Taurine Eye Drop Revenue Market Share by Type (2021-2032)
5 Taurine Eye Drop Market by Application
  1. 5.1 Taurine Eye Drop Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Taurine Eye Drop Sales by Application
  5. 5.2.1 Global Taurine Eye Drop Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Taurine Eye Drop Sales by Application (2021-2032)
  7. 5.2.3 Global Taurine Eye Drop Sales Market Share by Application (2021-2032)
  8. 5.3 Global Taurine Eye Drop Revenue by Application
  9. 5.3.1 Global Taurine Eye Drop Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Taurine Eye Drop Revenue by Application (2021-2032)
  11. 5.3.3 Global Taurine Eye Drop Revenue Market Share by Application (2021-2032)
6 Global Taurine Eye Drop Sales by Region
  1. 6.1 Global Taurine Eye Drop Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Taurine Eye Drop Sales by Region (2021-2032)
  3. 6.2.1 Global Taurine Eye Drop Sales by Region (2021-2026)
  4. 6.2.2 Global Taurine Eye Drop Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Taurine Eye Drop Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Taurine Eye Drop Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Taurine Eye Drop Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Taurine Eye Drop Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Taurine Eye Drop Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Taurine Eye Drop Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Taurine Eye Drop Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Taurine Eye Drop Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Taurine Eye Drop Revenue by Region
  1. 7.1 Global Taurine Eye Drop Revenue by Region
  2. 7.1.1 Global Taurine Eye Drop Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Taurine Eye Drop Revenue by Region (2021-2026)
  4. 7.1.3 Global Taurine Eye Drop Revenue by Region (2027-2032)
  5. 7.1.4 Global Taurine Eye Drop Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Taurine Eye Drop Revenue (2021-2032)
  8. 7.2.2 North America Taurine Eye Drop Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Taurine Eye Drop Revenue (2021-2032)
  11. 7.3.2 Europe Taurine Eye Drop Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Taurine Eye Drop Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Taurine Eye Drop Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Taurine Eye Drop Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Taurine Eye Drop Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Changchun Changqing Pharmaceutical Group Co., Ltd.
  2. 8.1.1 Changchun Changqing Pharmaceutical Group Co., Ltd. Company Information
  3. 8.1.2 Changchun Changqing Pharmaceutical Group Co., Ltd. Business Overview
  4. 8.1.3 Changchun Changqing Pharmaceutical Group Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Changchun Changqing Pharmaceutical Group Co., Ltd. Taurine Eye Drop Product Portfolio
  6. 8.1.5 Changchun Changqing Pharmaceutical Group Co., Ltd. Recent Developments
  7. 8.2 Changchun Dirui Pharmaceutical Co., Ltd.
  8. 8.2.1 Changchun Dirui Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Changchun Dirui Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Changchun Dirui Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Changchun Dirui Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  12. 8.2.5 Changchun Dirui Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Wuhan Wujing Pharmaceutical Co., Ltd.
  14. 8.3.1 Wuhan Wujing Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Wuhan Wujing Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Wuhan Wujing Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wuhan Wujing Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  18. 8.3.5 Wuhan Wujing Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shijiazhuang Grey Pharmaceutical Co., Ltd.
  20. 8.4.1 Shijiazhuang Grey Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Shijiazhuang Grey Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Shijiazhuang Grey Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shijiazhuang Grey Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  24. 8.4.5 Shijiazhuang Grey Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Shenyang Xingqi Eye Medicine Co., Ltd.
  26. 8.5.1 Shenyang Xingqi Eye Medicine Co., Ltd. Company Information
  27. 8.5.2 Shenyang Xingqi Eye Medicine Co., Ltd. Business Overview
  28. 8.5.3 Shenyang Xingqi Eye Medicine Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shenyang Xingqi Eye Medicine Co., Ltd. Taurine Eye Drop Product Portfolio
  30. 8.5.5 Shenyang Xingqi Eye Medicine Co., Ltd. Recent Developments
  31. 8.6 Shanghai Xiaofang Pharmaceutical Co., Ltd.
  32. 8.6.1 Shanghai Xiaofang Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Shanghai Xiaofang Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Shanghai Xiaofang Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Xiaofang Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  36. 8.6.5 Shanghai Xiaofang Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  38. 8.7.1 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  42. 8.7.5 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  44. 8.8.1 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  48. 8.8.5 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Ningxia Kangya Pharmaceutical Co., Ltd.
  50. 8.9.1 Ningxia Kangya Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Ningxia Kangya Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Ningxia Kangya Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ningxia Kangya Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  54. 8.9.5 Ningxia Kangya Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Mentholatum
  56. 8.10.1 Mentholatum Company Information
  57. 8.10.2 Mentholatum Business Overview
  58. 8.10.3 Mentholatum Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mentholatum Taurine Eye Drop Product Portfolio
  60. 8.10.5 Mentholatum Recent Developments
  61. 8.11 Liaoning Yifan Pharmaceutical Co., Ltd.
  62. 8.11.1 Liaoning Yifan Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Liaoning Yifan Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Liaoning Yifan Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Liaoning Yifan Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  66. 8.11.5 Liaoning Yifan Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd.
  68. 8.12.1 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Company Information
  69. 8.12.2 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Business Overview
  70. 8.12.3 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Taurine Eye Drop Product Portfolio
  72. 8.12.5 Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Recent Developments
  73. 8.13 Roxy Pharmaceutical Shijiazhuang Co., Ltd.
  74. 8.13.1 Roxy Pharmaceutical Shijiazhuang Co., Ltd. Company Information
  75. 8.13.2 Roxy Pharmaceutical Shijiazhuang Co., Ltd. Business Overview
  76. 8.13.3 Roxy Pharmaceutical Shijiazhuang Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Roxy Pharmaceutical Shijiazhuang Co., Ltd. Taurine Eye Drop Product Portfolio
  78. 8.13.5 Roxy Pharmaceutical Shijiazhuang Co., Ltd. Recent Developments
  79. 8.14 Jiangxi Zhenshiming Pharmaceutical Co., Ltd.
  80. 8.14.1 Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  84. 8.14.5 Jiangxi Zhenshiming Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Jiangsu Yuanheng Pharmaceutical Co., Ltd.
  86. 8.15.1 Jiangsu Yuanheng Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Jiangsu Yuanheng Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Jiangsu Yuanheng Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Jiangsu Yuanheng Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  90. 8.15.5 Jiangsu Yuanheng Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Jiangsu Jibei Pharmaceutical Co., Ltd.
  92. 8.16.1 Jiangsu Jibei Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Jiangsu Jibei Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Jiangsu Jibei Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Jiangsu Jibei Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  96. 8.16.5 Jiangsu Jibei Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Hubei Zhongjia Pharmaceutical Co., Ltd.
  98. 8.17.1 Hubei Zhongjia Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Hubei Zhongjia Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Hubei Zhongjia Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Hubei Zhongjia Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  102. 8.17.5 Hubei Zhongjia Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd.
  104. 8.18.1 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  108. 8.18.5 Hubei Yuanda Tiantianming Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Heilongjiang Tianlong Pharmaceutical Co., Ltd.
  110. 8.19.1 Heilongjiang Tianlong Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Heilongjiang Tianlong Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Heilongjiang Tianlong Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Heilongjiang Tianlong Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  114. 8.19.5 Heilongjiang Tianlong Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Hangzhou Guoguang Pharmaceutical Co., Ltd.
  116. 8.20.1 Hangzhou Guoguang Pharmaceutical Co., Ltd. Company Information
  117. 8.20.2 Hangzhou Guoguang Pharmaceutical Co., Ltd. Business Overview
  118. 8.20.3 Hangzhou Guoguang Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Hangzhou Guoguang Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  120. 8.20.5 Hangzhou Guoguang Pharmaceutical Co., Ltd. Recent Developments
  121. 8.21 Guangdong Zhongsheng Pharmaceutical Co., Ltd.
  122. 8.21.1 Guangdong Zhongsheng Pharmaceutical Co., Ltd. Company Information
  123. 8.21.2 Guangdong Zhongsheng Pharmaceutical Co., Ltd. Business Overview
  124. 8.21.3 Guangdong Zhongsheng Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Guangdong Zhongsheng Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  126. 8.21.5 Guangdong Zhongsheng Pharmaceutical Co., Ltd. Recent Developments
  127. 8.22 Guangdong Matsushita Pharmaceutical Co., Ltd.
  128. 8.22.1 Guangdong Matsushita Pharmaceutical Co., Ltd. Company Information
  129. 8.22.2 Guangdong Matsushita Pharmaceutical Co., Ltd. Business Overview
  130. 8.22.3 Guangdong Matsushita Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Guangdong Matsushita Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  132. 8.22.5 Guangdong Matsushita Pharmaceutical Co., Ltd. Recent Developments
  133. 8.23 Guangdong Nanguo Pharmaceutical Co., Ltd.
  134. 8.23.1 Guangdong Nanguo Pharmaceutical Co., Ltd. Company Information
  135. 8.23.2 Guangdong Nanguo Pharmaceutical Co., Ltd. Business Overview
  136. 8.23.3 Guangdong Nanguo Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Guangdong Nanguo Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  138. 8.23.5 Guangdong Nanguo Pharmaceutical Co., Ltd. Recent Developments
  139. 8.24 Guangdong Hengjian Pharmaceutical Co., Ltd.
  140. 8.24.1 Guangdong Hengjian Pharmaceutical Co., Ltd. Company Information
  141. 8.24.2 Guangdong Hengjian Pharmaceutical Co., Ltd. Business Overview
  142. 8.24.3 Guangdong Hengjian Pharmaceutical Co., Ltd. Taurine Eye Drop Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Guangdong Hengjian Pharmaceutical Co., Ltd. Taurine Eye Drop Product Portfolio
  144. 8.24.5 Guangdong Hengjian Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Taurine Eye Drop Value Chain Analysis
  2. 9.1.1 Taurine Eye Drop Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Taurine Eye Drop Production Mode & Process
  6. 9.2 Taurine Eye Drop Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Taurine Eye Drop Distributors
  9. 9.2.3 Taurine Eye Drop Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst